Bladder issues are one of those symptoms of multiple sclerosis (MS) that nobody really prepares you for. People often talk about mobility problems, fatigue, or vision changes — not the sudden, urgent need to find a bathroom or the constant awareness of the one closest…
People with multiple sclerosis (MS) have a nearly fivefold increased risk of developing dementia compared with those without the disease, according to a real-world study in Taiwan. Treatment with disease-modifying therapies significantly reduced the risk for neurodegenerative dementias, or dementias associated with the loss of…
Myelin-making cells in some areas of the brain were more resistant to injury in a mouse model of myelin damage than the same cells in other brain regions. Researchers created detailed, brain-wide maps showing exactly where myelin-making cells, known as oligodendrocytes, are located in the…
For a heart-healthy win that feels like spring on a plate, you can’t beat this easy sheet pan Lemon-Herb Salmon & Spring Greens. Salmon is packed with Omega-3 fatty acids that support cardiovascular health. Ingredients: Directions: Enjoy!! Source: blog.mymsaa.org
Tweet Kuiper KL, Bogers L, Rip J, van Hasselt Y, Melief MJ, Wierenga-Wolf AF, Klein Kranenbarg RAM, Bindels E, van de Werken HJG, de Beukelaar J, Smets I, Wokke B, Smolders J, van Luijn MM. Integrin β1 Demarks Precursors of Brain-Residing Antibody-Secreting Cells in Multiple…
The post From our CEO appeared first on MS Australia. Source: www.msaustralia.org.au
The post Latest trial results show BTK inhibitor fenebrutinib effective in primary progressive MS appeared first on MS Australia. Source: www.msaustralia.org.au
I have monthly appointments with a psychiatrist where I mainly discuss my experience with sleep medications that he prescribes for me. You see, I struggle with serial insomnia hence the regular appointments with the shrink. In the course of our meeting, we talk about lots…
The Accelerated Cure Project for Multiple Sclerosis (ACP) has launched a new community-led initiative designed to ensure that people from underrepresented multiple sclerosis (MS) communities help set priorities for future MS research. sp The initiative, called Prioritized Research Agenda Development and Advancement (PRADA), creates a…
In real-world clinical practice, Ocrevus (ocrelizumab) showed sustained effectiveness in people with relapsing forms of multiple sclerosis (MS), with most patients remaining free from long-term worsening of disability over four years, according to a new study. Relapse rates and MRI disease activity were also low…